Difference between revisions of "Part:BBa K5407001"

Revision as of 08:30, 15 September 2024

si-TEAD4-1 sequence

Sequence and Features

Assembly Compatibility:

10
COMPATIBLE WITH RFC[10]
12
COMPATIBLE WITH RFC[12]
21
COMPATIBLE WITH RFC[21]
23
COMPATIBLE WITH RFC[23]
25
COMPATIBLE WITH RFC[25]
1000
COMPATIBLE WITH RFC[1000]

@@ Line 1: / Line 1: @@
 __NOTOC__
 <partinfo>BBa_K5407001 short</partinfo>
 <!-- Add more about the biology of this part here
 ===Usage and Biology===
+The HIPPO pathway is a key regulatory pathway in tumor development, with TEAD4 (TEA Domain Family Member 4) being a core transcription factor that promotes the growth and spread of CRC cancer cells [1]. si-TEAD4-1 sequence are designed to target to the untranslated region (UTR) of TEAD4. When siRNA reach the cell cytoplasm, it could binds with the RNA-induced silencing complex (RISC) [2]. Binding with the RISC leads to degradation of the sense strand, whereas the antisense strand continues to be incorporated in the RISC [3]. The RISC then makes multiple mRNA cleavages to downregulate TEAD4 gene expression.
+===Design===
+We designed the siRNA against TEAD4 by a special database (https://www.invivogen.com/sirnawizard/). After we input the TEAD4 gene name and sequence, the database would output all the possible siRNA sequence (Figure 1). We chose two pairs of siRNAs with the least off-target possibility.
+                                 https://static.igem.wiki/teams/5407/in.png
+                               Figure 1 Design of siRNA Sequences Targeting TEAD4
+===Reference===
+Reference
+[1] Evelien, Dekker,Pieter J, Tanis,Jasper L A, Vleugels et al. Colorectal cancer.[J] .Lancet, 2019, 394: 0.
+[2] Shigeyoshi, Kijima,Takahiro, Sasaki,Koichi, Nagata et al. Preoperative evaluation of colorectal cancer using CT colonography, MRI, and PET/CT.[J] .World J Gastroenterol, 2014, 20: 0.
+[3] Robert H, Hollis,Daniel I, Chu,Healthcare Disparities and Colorectal Cancer.[J] .Surg Oncol Clin N Am, 2022, 31: 0.
 <!-- -->